Trends over time in Helicobacter pylori gastritis in Kenya

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 6, 2000, Pages 617-621

  McFarlane, Gordon A ^a,e   Wyatt, Judith ^b   Forman, David ^c   Lachlan, Geoffrey W ^d  

^a PCEA Chogoria Hospital   (Kenya)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d Belford Hospital   (United Kingdom)

^e NONE   (United Kingdom)

Author keywords

Atrophic gastritis; Chronic gastritis; Follow up; Gastric cancer; Helicobacter pylori; Intestinal metaplasia

Indexed keywords

AMOXICILLIN;

ADULT; ARTICLE; CANCER RISK; DYSPLASIA; ENDOSCOPY; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE INFECTION; INTESTINE METAPLASIA; KENYA; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; PRIORITY JOURNAL; RURAL AREA; STOMACH CANCER; STOMACH MUCOSA;

EID: 0033918011     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012060-00007     Document Type: Article

References (31)

1. 1 Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i:1273.
2. 2 Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i:1273-1275.
3. 3 Parsonnet J, Hansen S, Rodriguez L, Gleb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330:1267-1271.
4. 4 Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342:571-574.
5. 5 Wotherspoon AC, Doglioni C, Diss TC. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342:575-577.
6. 6 Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Edit S, Stolte M. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995; 345:1591-1594.
7. 7 Sipponen P, Kekki M, Siurala M. The Sydney System: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 1991; 6:244-251.
8. 8 Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345:1525-1528.
9. 9 Sakaki N, Momma K, Egawa N, Yamada Y, Kan T, Ishiwata J. The influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer. Eur J Gastroenterol Hepatol 1995; 7(suppl 1):59-62.
10. 10 Morson BC. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 1955; 9:377-385.
11. 11 Sipponen P, Kekki M, Siurala M. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Cancer 1983; 52:1062-1068.
12. 12 Correa P. The epidemiology and pathogenesis of chronic gastritis: three etiologic entities. Front Gastrointest Res 1980; 6:98-108.
13. 13 Cahill RJ, Sant S, Beattie S, Hamilton H, O'Morain C. Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer. Eur J Gastroenterol Hepatol 1994; 6:1123-1127.
14. 14 Drake IM, Warland D, Carswell N, Schorah CJ, Mapstone M, Axon ATR, et al. Reactive oxygen species (ROS) activity and damage in Helicobacter pylori associated gastritis (HPG) - effect of eradication therapy [Abstract]. Gut 1995; 37(suppl 1):A39.
15. 15 Ihamaki T, Kekki M, Sipponen P, Siurala M. The sequelae and course of chronic gastritis during a 30-34-year bioptic follow-up study. Scand J Gastroenterol 1985; 20:485-491.
16. 16 Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990; 50:4737-4740.
17. 17 Villako K, Kekki M, Maaroos HI, Sipponen P, Uibo R, Tammur R, Tamm A. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol 1991; 26(suppl 186):135-141.
18. 18 Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6:209-222.
19. 19 Plummer M, Buiatti E, Lopez G, Peraza S, Vivas J, Oliver W, Munoz N. Histological diagnosis of precancerous lesions of the stomach: a reliability study. Int J Epidemiol 1997; 26:716-720.
20. 20 Holcombe C. Helicobacter pylori: the African enigma. Gut 1992; 33:429-431.
21. 21 The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer [see comments]. Lancet 1993; 341:1359-1362 (Erratum Lancet 1993; 341:1668).
22. 22 Forman D, Sitas F, Newell DG, Stacey AR, Boreham J, Peto R, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46:608-611.
23. 23 Correa P, Fox J, Fontham E, Ruiz B, Lin Y, Zavala D, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66:2569-2574.
24. 24 Meining A, Stolte M. Different expression of H. pylori-gastritis in relatives of gastric carcinoma patients. Gut 1996; 39(suppl 2):17-18.
25. 25 Scott N, Lansdown M, Diament R, Rathbone B, Murday V, Wyatt JI, et al. Helicobacter gastritis and intestinal metaplasia in a gastric cancer family. Lancet 1990; 335:728.
26. 26 Webb PM, Forman D, Newell D, Covacci A, Crabtree JE, Eurogast Study Group. An international association between prevalence of infection with CagA positive strains of H. pylori and mortality from gastric cancer [Abstract]. Gut 1996; 39(suppl 2):16.
27. 27 Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-2115.
28. 28 Perez-Perez GI, Bhat N, Gaensbauer J, Fraser A, Taylor D, Kuipers EJ, et al. Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections. Int J Cancer 1997; 72:453-456.
29. 29 Kneller RW, Guo WD, Hsing AW, Chen JS, Blot WJ, Li JY, et al. Risk factors for stomach cancer in sixty-five Chinese counties. Cancer Epidemiol Biomarkers Prev 1992; 1:113-118.
30. 30 Risch HA, Jain M, Choi NW, Fodor JG, Pfeiffer CJ, Howe GR, et al. Dietary factors and the incidence of cancer of the stomach. Am J Epidemiol 1985; 122:947-957.
31. 31 Hu J, Zhang S, Jia E, Wang Q, Liu S, Liu Y, et al. Diet and cancer of the stomach: a case-control study in China. Int J Cancer 1988; 41:331-335.